Dr. Essel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5308 Harroun Rd
#285
Sylvania, OH 43560Phone+1 419-824-5633Fax+1 419-824-5953
Education & Training
- University of Oklahoma Health Sciences CenterFellowship, Gynecologic Oncology, 2017 - 2020
- University of Texas Health Science Center at HoustonResidency, Obstetrics and Gynecology, 2013 - 2017
- The University of Texas Health Science Center at San AntonioClass of 2013, MD
Certifications & Licensure
- OH State Medical License 2021 - 2025
- TN State Medical License 2020 - 2022
- OK State Medical License 2017 - 2021
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- 7 citationsPathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?Monica Hagan Vetter, Stacy A. Smrz, Paola A. Gehrig, K. Peng, Keitaro Matsuo
Gynecologic Oncology. 2020-11-01 - 22 citationsPreclinical Efficacy and Involvement of AKT, mTOR, and ERK Kinases in the Mechanism of Sulforaphane against Endometrial Cancer.Rajani Rai, K.G. Essel, Doris M. Benbrook, Justin Garland, Yan D. Zhao
Cancers. 2020-05-18 - 115 citationsRecurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study.Shitanshu Uppal, Paola A. Gehrig, K. Peng, Kristin Bixel, Koji Matsuo
Journal of Clinical Oncology. 2020-02-07
Journal Articles
- Preclinical Efficacy and Involvement of AKT, mTOR, and ERK Kinases in the Mechanism of Sulforaphane against Endometrial CancerRajani Rai, Kathleen Essel, Doris Benbrook, Justin Garland, Yan Zhao, Vishal Chandra, Cancers, 5/18/2020
- Niraparib for the treatment of ovarian cancerKathleen G Essel, Kathleen N Moore, Expert Review of Anticancer Therapies, 8/18/2018
Press Mentions
- No Man is an IslandMarch 29th, 2021
Professional Memberships
- Society of Gynecologic OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: